This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

7th International Chronic Total Occlusion Summit in New York City

November 16th, 2009

WHAT:
The Seventh International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions. This year's summit will include:

  • Presentations from experts in the field
  • Case review sessions
  • Thematically organized live coronary CTO cases broadcast in high definition from Scripps Clinic and Research Foundation (La Jolla, CA) and Columbia University Medical Center (New York, NY)
  • Essential techniques, tips, and information for determining how to treat CTOs

WHY:
Chronic total occlusions of coronary arteries represent one of the greatest challenges to interventional cardiologists. Successful revascularization of CTOs has been strongly associated with improved left ventricular function, freedom from angina, a reduced risk of revascularization and in several studies increased survival. Through new guidewires, novel devices, appropriate patient selection, and improved operator technique, the success rate for recanalization of complex CTOs is increasing. The novel retrograde approach to CTOs has been introduced as an alternative route for recanalization of otherwise difficult or impossible lesions.

WHEN:
February 4 - 5, 2010

WHERE:
New York Marriott Marquis Hotel

New York, NY

Source: Cardiovascular Research Foundation

Citation: 7th International Chronic Total Occlusion Summit in New York City (2009, November 16) retrieved 22 August 2026 from https://sciencex.com/wire-news/19832250/7th-international-chronic-total-occlusion-summit-in-new-york-cit.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.